Thyroid Diseases: all 976 studies

Page 3 of 10. Open to participants first (197), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid CancerCompletedNCT05132478Not applicableResults posted
• IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATCTerminatedNCT05059470Phase 2Results posted
• Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total ThyroidectomyCompletedNCT05022667Not applicableResults posted
• Energy Metabolism in Thyroidectomized PatientsCompletedNCT04782856Phase 2Results posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye DiseaseCompletedNCT04583735Phase 4Results posted
• Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid CancerCompletedNCT04552769Phase 2Results posted
• Preoperative Steroids in Autoimmune Thyroid DiseaseCompletedNCT04542278Phase 4Results posted
• AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation AidCompletedNCT04472026Not applicableResults posted
• Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.CompletedNCT04281875Not applicableResults posted
• Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid NodulesCompletedNCT04277455Not applicableResults posted
• Treatment of Papillary Thyroid Carcinoma With Radiofrequency AblationCompletedNCT04129411Not applicableResults posted
• A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid ParticipantsCompletedNCT04124705Phase 2Results posted
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsActive, not recruitingNCT03899792Phase 1/2Results posted
• Quality of Life After Interventional Thyroid TreatmentCompletedNCT03880578Results posted
• Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerTerminatedNCT03630120Phase 2Results posted
• Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid NodulesCompletedNCT03535974Not applicableResults posted
• Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid CancerTerminatedNCT03506048Phase 2Results posted
• Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid CancerTerminatedNCT03463889Phase 2Results posted
• Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical StudyCompletedNCT03298867Phase 3Results posted
• Nivolumab Plus Ipilimumab in Thyroid CancerCompletedNCT03246958Phase 2Results posted
• Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid CancerCompletedNCT03211117Phase 2Results posted
• Ultrasound Elastography in Imaging Patients With Thyroid NodulesCompletedNCT03174925Not applicableResults posted
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Active, not recruitingNCT03157128Phase 1/2Results posted
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid CancerTerminatedNCT03131206Phase 1/2Results posted
• Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid CancersTerminatedNCT03109847Phase 2Results posted
• Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the ThyroidCompletedNCT03106337Not applicableResults posted
• Pembrolizumab in Recurrent or Metastatic Medullary Thyroid CancerCompletedNCT03072160Phase 2Results posted
• 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) PatientsTerminatedNCT03065218Phase 4Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• "Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"TerminatedNCT03032198Not applicableResults posted
• CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid CancerTerminatedNCT03002623Phase 2Results posted
• Celecoxib for Thyroid Eye DiseaseTerminatedNCT02845336Phase 2Results posted
• A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety ProfileCompletedNCT02702388Phase 2Results posted
• Pembrolizumab in Anaplastic/Undifferentiated Thyroid CancerCompletedNCT02688608Phase 2Results posted
• A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)TerminatedNCT02657369Phase 2Results posted
• Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid CancerTerminatedNCT02408887Phase 2Results posted
• Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid CancerCompletedNCT02393690Phase 2Results posted
• 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and OsteoporosisCompletedNCT02304757Not applicableResults posted
• A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid CancerCompletedNCT02244463Phase 1/2Results posted
• Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and ParathyroidectomyCompletedNCT02205801Not applicableResults posted
• Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid CancerCompletedNCT02152137Phase 2Results posted
• Central Neck Dissection in Patients With Clinical Node Negative Thyroid CancerCompletedNCT02138214Phase 2Results posted
• Percutaneous Ethanol Injection for Primary Papillary Thyroid MicrocarcinomaTerminatedNCT01974284Not applicableResults posted
• Acupuncture for Reduction of InflammationCompletedNCT01937520Not applicableResults posted
• Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary StudyCompletedNCT01927887Not applicableResults posted
• Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid CancerCompletedNCT01882816Phase 2Results posted
• Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid CancerCompletedNCT01876784Phase 3Results posted
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye DiseaseCompletedNCT01868997Phase 2Results posted
• QUILT-3.006 for Recurrent Medullary Thyroid CancerCompletedNCT01856920Phase 2Results posted
• Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid CancerTerminatedNCT01843062Phase 3Results posted
• Ponatinib for Advanced Medullary Thyroid CancerTerminatedNCT01838642Phase 2Results posted
• Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerCompletedNCT01811212Phase 2Results posted
• Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye DiseaseCompletedNCT01798966Not applicableResults posted
• A Study of E7080 in Subjects With Advanced Thyroid CancerCompletedNCT01728623Phase 2Results posted
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsCompletedNCT01709435Phase 1Results posted
• Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaCompletedNCT01661179Phase 1/2Results posted
• Pioglitazone in Thyroid CancersCompletedNCT01655719Phase 2Results posted
• Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436CompletedNCT01534897Not applicableResults posted
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerCompletedNCT01502410Phase 2Results posted
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)CompletedNCT01321554Phase 3Results posted
• Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid CancerCompletedNCT01270321Phase 2Results posted
• A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)CompletedNCT01240590Phase 1/2Results posted
• Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid CancerCompletedNCT01236547Phase 2Results posted
• Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid CancerCompletedNCT01208051Phase 1/2Results posted
• Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid SurgeryCompletedNCT01189292Phase 3Results posted
• A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell OriginCompletedNCT01182285Phase 2Results posted
• Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid CancerCompletedNCT01025453Phase 2Results posted
• Trial of LBH589 in Metastatic Thyroid CancerCompletedNCT01013597Phase 2Results posted
• Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerCompletedNCT00984282Phase 3Results posted
• Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244CompletedNCT00970359Not applicableResults posted
• A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)TerminatedNCT00923247Phase 1/2Results posted
• Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by HistologyCompletedNCT00784303Phase 2Results posted
• Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00729157Phase 2Results posted
• Assess Vitamin D Levels in Those With & Without Thyroid CancerCompletedNCT00719615Results posted
• A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedNCT00718770Early Phase 1Results posted
• Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)CompletedNCT00706381Phase 3Results posted
• Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid CancerCompletedNCT00704730Phase 3Results posted
• Sutent Adjunctive Treatment of Differentiated Thyroid CancerCompletedNCT00668811Phase 2Results posted
• Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerCompletedNCT00654238Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid CancerCompletedNCT00625846Phase 2Results posted
• A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With PaclitaxelTerminatedNCT00603941Phase 1/2Results posted
• An Initial Study of Lithium in Patients With Medullary Thyroid CancerTerminatedNCT00582712Phase 2Results posted
• Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive IodineCompletedNCT00559949Phase 2Results posted
• Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompletedNCT00537095Phase 2Results posted
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2Results posted
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid CancerCompletedNCT00514046Phase 1/2Results posted
• Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid CancerTerminatedNCT00507429Phase 2/3Results posted
• Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled TrialCompletedNCT00472446Phase 2/3Results posted
• Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid CancerCompletedNCT00390325Phase 2Results posted
• Study Of AG-013736 In Patients With 131I-Refractory Thyroid CancerCompletedNCT00389441Phase 2Results posted
• Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryCompletedNCT00381641Phase 2Results posted
• A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerCompletedNCT00358956Phase 2Results posted
• REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasCompletedNCT00287287Phase 2Results posted
• Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid CancerCompletedNCT00251316Phase 2Results posted
• Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid CancerCompletedNCT00181168Phase 2Results posted
• Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerCompletedNCT00134043Phase 2Results posted
• Sorafenib in Treating Patients With Advanced Anaplastic Thyroid CancerTerminatedNCT00126568Phase 2Results posted
• Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid CancerCompletedNCT00118248Phase 2Results posted
• Trial Evaluating Gleevec in Patients With Anaplastic Thyroid CarcinomaTerminatedNCT00115739Phase 2Results posted

← Thyroid Diseases overview